Bioverativ Therapeutics, Inc.
H‑1B Sponsor Verified
Yes. Bioverativ Therapeutics, Inc. filed 32 H-1B labor condition applications (LCAs) with the U.S. Department of Labor from 2019–2026, including 4 so far in 2026. The average H-1B salary is $103,474 and the most sponsored role is Senior Associate, Statistical Programming.
Source: U.S. Department of Labor LCA disclosure data. Most recent filing on record: Jun 5, 2026.
LinkedIn ↗Latest Year Filings
4
In 2026
↗ Filter by year
Total H‑1B Filings
32
Since 2020
↗ View records
Avg Annual Salary
$103,474
All years combined
↗ View chart
Top Role
Senior Associate, Statistical Prog…
↗ Click to filter
Filing trend
H‑1B filings by year for Bioverativ Therapeutics, Inc.
| Year | LCA filings | Avg salary |
|---|---|---|
| 2026 | 4 | $132,153 |
| 2025 | 2 | $102,721 |
| 2023 | 6 | $116,120 |
| 2022 | 5 | $79,938 |
| 2021 | 5 | $121,819 |
| 2020 | 8 | $88,221 |
| 2019 | 2 | $82,930 |
Click a bar to filter records
Yearly filings & average salary · swipe to explore
SponsorStats AI
Summary